One Versus Twice Daily Administration of Multiple Cardiovascular Agents in Patients With Ischemic Heart Disease
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT04148820
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Registry
-
NCT04148820
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT04148820. Randomized; no masking; primary purpose treatment. Start 2019-11-01 (anticipated); primary completion 2021-10-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- One Versus Twice Daily Administration of Multiple Cardiovascular Agents in Patients With Ischemic Heart Disease
- Acronym
- ONCE
- Condition
- Ischemic Heart Disease
- Intervention (Drug)
- Aspirin, Atorvastatin, Perindopril
- Lead sponsor
- University of Roma La Sapienza
Record details
- Record id
cardio:ct-nct04148820- Content hash
a52a9ef97321e74e9e4e4747673d737835f7167f6d1cf5de4be4669475e262c6